Implementation of a cost effective strategy to prevent neonatal infection by group B-hemolytic streptococcus

Completed

• Conditions: early onset group B streptococcus disease; 10004018; 10028920

• Registration Number: NL-OMON37307
• Lead Sponsor: TNO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 1260

Inclusion Criteria

Midwives, gynecologists and pediatricians working in one hospital and the region around this hospital. All pregnant women in care of the midwive or gynecologist in the hospital region from pregnancy week 30 onwards.

Exclusion Criteria

Pregnant women who refuse the 'new' policy of GBS prevention are offered the care as usual.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Percentage adherence to the different prevention strategies compared with the<br /><br>percentage adherence to the current Dutch guideline. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Adherence of the prevention strategies, clinical and process outcomes, cost<br /><br>effectiveness analysis of the different prevention strategies, experiences of<br /><br>pregnant women and care providers.<br /><br></p><br>